Live Oncology News with Latest Updates

Live oncology news and developments with the latest updates. Check out current oncology news stories and find out what happened, what is going on with oncology. Recent news updates about oncology
Discovery of an adaptation process key to survival of Mycoplasma genitalium in urogenital tract
More than 110 Dana-Farber-affiliated physicians recognized as Top Doctors
Vaccitech Oncology Limited and Ludwig Institute for Cancer Research enter collaboration with Cancer
Dana-Farber research supports new indication for a prostate cancer drug
Myles Brown, MD receives 2019 AACR Distinguished Lectureship in Breast Cancer Research award
Breast cancer patients not told about fertility options
Japan’s biggest pharma co., Takeda, teams with Melbourne’s BioCurate to expedite new drug development
International collaboration yields insights into childhood leukemia risk
Acalabrutinib receives TGA approval for CLL and SLL cancers
St. Jude researchers among most highly cited in 2019
Dozens of UCLA scientists rank among world’s most-cited researchers
New research for improved treatment of cancer and heart attacks is und
A computer model has learned to detect prostate cancer
ProCan: how a database of cancer proteins may transform treatment
More progress on cancer medicines
Dana-Farber Cancer Institute launches new national advertising campaign
Dana-Farber Cancer Institute faculty elected to National Academy of Medicine
Men urged to be aware of breast cancer risks
Eric Winer, MD honored with Jill Rose Award by Breast Cancer Research Foundation
MD Anderson and Varian partner to optimize radiation oncology treatment
Exercise may reduce risk of cancer recurrence and improve survival rates
At UConn Health, Breast Cancer Journey is Handled with Care
Ludwig researchers develop machine learning tool to refine personalized immunotherapy
Cancer cells can re-use apparent ‘dead end metabolites’
Dana-Farber/Brigham and Women’s Cancer Center Offers Novel MRI-Guided Radiation Therapy for Cancer
Do Costs of Cancer Drugs Receive Enough Attention?
Provisional application receives approval through first international collaborative review initiative between TGA, FDA and HC
Provisional approval of lenvatinib in combination with pembrolizumab for treatment of advanced endometrial carcinoma
AdAlta secures licensing deal for i-body platform with global medical technology and diagnostics
New mathematical model can improve radiation therapy of brain tumours
Aesthetics of skin cancer therapy may vary by treatment type
International Collaboration to Improve Cancer Care
BRCA1/2 Genetic Testing Recommendations Still Leave Issues Unresolved
UPMC East Cancer Program Earns National Accreditation
Advance Care Planning Seminar kicks off in Melbourne
Rushed cancer announcement underwhelming
Inherited BRCA2 mutations linked to increased risk of childhood lymphoma
Dana-Farber physician-scientist David Braun honored as Next Gen Innovator
Dana-Farber scientists and associates receive major grant from Gray Foundation for research into
Researchers discover new genetic link to premenopausal breast cancer
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer
Unmasking mutant cancer cells
Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients
New anticancer agents have potential to better control tumor growth in nearly every cancer
A simple text could make difference between life and death
Researchers Identify New Way to Make Cancer Self Destruct
Penn study finds protons are effective, safe when given in higher doses
Ending needless chemotherapy for breast cancer